Targeting the Thymus to Transform Outcomes in Autoimmune Disease
- Comparison of regulatory T cells, peripheral regulatory T cells, and alternative immunetolerance mechanisms, highlighting their distinct biology and therapeutic relevance
- Reviewing current preclinical and emerging clinical evidence, outlining how each approach contributes to immune modulation
- Insights into key challenges, translational hurdles, and notable successes that are shaping the future development of targeted immunotherapies